15 days ago
Yesterday I exposed how Cavendish, the Nomad, to Skinbiotherapeutics (SBTX) had banned its boss Stuart Ashman from doing interviews with me as the videos would be behind a paywall. It gets worse, as a kind reader points out.
17 days ago
This is Orwellian and shows that Giles Balleny of Nomad Cavendish (formerly Finncrap & Cenkos pre merger) is either thick as pig shit or morally bankrupt or both. Given he works for Cavendish I reckon it is both. He has ordered Stuart Ashman of Skinbiotherapeutics (SBTX) to record no more videos with me.
26 days ago
In today’s bearcast I start with happy events in London last night to cheer both myself and the Euroloon Jonathan Price. Then it is on to Verditek (VDTK), Canadian Overseas (COPL), Regtech Open (FRAUD) and Supply@ME Capital (FRAUD) all four of which owe us statements. Then Kefi Gold & Copper (KEFI) and Skinbiotherapeutics (SBTX).
51 days ago
I have emailed Stuart Ashman, the boss of Skinbiotherapeutics (SBTX) this morning with, what I believe to be, a helpful suggestion.
61 days ago
I start with it being the first day of Advent and a moan about folks starting Christmas far too early. Then onto Skinbiotherapeutics (SBTX), why I am not selling and a suggestion for Stuart Ashman, a serious one, on how he can regain investor trust at a stroke. Then it is Tintra (TNT), Ceres Power (CWR), free speech on this website, Totally (TLY), Vast Resources (VAST) and Rua Life Sciences (RUA),the sponsor of today’s ouzo moment.
61 days ago
I still think Skinbiotherapeutics (SBTX) shares are cheap after results which were snuck out after hours yesterday. However, I want to flag up that for a company with sales lower than that of my local CO-OP and which spunked c£3 million in each of the last two years, the boardroom pay is obscene and just cannot be justified. The worst offender is the Sus barbatus himself, CEO Stuart Ashman.
65 days ago
I guess that while Stuart Ashman might have taken me off his Christmas card list after my recent bearcast on Skinbiotherapeutics (SBTX), Steve O’Hara at Optibiotix (OPTI) seems to agree with my analysis. We have swapped emails this morning after the publication of a TR1.
70 days ago
SkinBioTherapeutics (SBTX) has announced a placing and “retail offer” at 19p per share to raise, respectively, a minimum of £3 million and up to £0.25 million, with CEO Stuart Ashman stating this is needed “to help with the current commercialisation and development strategy of AxisBiotix in skin health, with our latest venture beginning in acne, as well as providing a stronger financial base to support our strategic partnering discussions around three of our other business pillars. The funding will also support us with working capital and strengthen our balance sheet”. Tom Winnifrith has applied for shares in the offer and we suggest you do too BUT Ashman is talking bollocks and we will be slashing our target price from 150p.
72 days ago
In this bonus Bearcast, I explain why I am cutting my target price materially for Skinbiotherapeutics (SBTX) but still see this as a potential five bagger. I am furious with Stuart Ashman who is greedy and has not delivered. And I think the company’s broker, Cavendish, has a lot of questions to answer. I warn you that Matthew’s Dog and Catriona will love this podcast.
76 days ago
I have been involved with the stockmarket for 33 years. I have done almost every job going: analyst, CEO, fund manager – crap one – even, don’t laugh, compliance officer so I get really fucked off when folks lecture me about what the rules are, especially when they clearly don’t know them themselves. I really do not like being patronized and that brings me to Stuart Ashman and Skinbiotherapeutics (SBTX) where I am, of course, a loyal shareholder.
232 days ago
Apologies for the introduction, long covid. In today’s podcast I discuss why what Gary or I say about a given stock does not matter, in the long run what matters is cash generation or lack of it. I discuss what Stuart Ashman and Steve O’Hara said about Gary’s bear piece yesterday. I discuss house prices. And I flag up that there are now just 12 tickets left for Sharestock so if you want to come book now HERE
265 days ago
I am back with these bonus video shows. I am still re-adjusting myself to Zoom so if my face looks a bit funny in part 4 there is a reason. In this show I interview Stuart Ashman of Skinbiotherapeutics (SBTX), dissect that interview myself and then ask if Oacdo (OCDO) really is the Number 1 FTSE 100 short or one for the bears to dodge. I hope you enjoy the show.
308 days ago
I am told by at least one reader that a 1 million shares sale in Skinbiotherapeutics (SBTX) MUST be Optibiotix (OPTI). The bulletin boards are full of ill-informed speculation. I am in a good mood today because West Ham are Massive so I shall not label such folks morons. Okay I will. They are morons. I have swapped emails with both Steve O’Hara of Optibiotix and Stuart Ashman of Skins.
480 days ago
I do not always agree with Mr Lemming Investor but for what it is worth we are both still bulls of Skinbiotherapeutics (SBTX). He posted this Q&A with Stuart Ashman the other day and it is worth a read. Over to the Lemming:
481 days ago
SkinBioTherapeutics (SBTX) has announced no-one watching o’clock (4:30pm) results for its year ended 30th June 2022, with CEO Stuart Ashman stating “this financial year has been a mixed one for the group”. With the results coming with a potentially £3.5 million equity raise (albeit including an up to £1 million “retail offer”) at 16p per share, we’ve got some other words for it but where does this all leave the company now?
592 days ago
Let us be clear. When I said that Staurt Ashman said that month on month sales doubled in both July and August I said so because the bearded loon said so in an email to me. For him to backtrack as he does in this interview and suggest that “Mr Angry” is a bit confused, therefore makes me a bit more er….angry. If you have an hour of your life to spare, enjoy.
606 days ago
In today’s bearcast I look in detail at Cake Box (CBOX), nanosynth (NNN) and Skinbiotherapeutics (SBTX).
695 days ago
I discuss both these corporates, and remind the 94% of you yet to support Rogue Bloggers for Woodlarks: please do so, HERE. Then, I discuss Stuart Ashman of Skinbiotherapitics (SBTX), who has made me look like a complete git (again), as he withdraws from ShareStock. But, I will announce another BIG-name speaker tomorrow, and will replace Stuart. So, make sure you book your tickets, HERE. Then, I look at Cellular Goods (CBX) and Guild ESports (GILD), the David Beckham dogs.
762 days ago
I start with Mello Events, which last night exposed itself as a PR promoter, failing to allow any questions about the elephant in the room: musicMagpie(MMAG). Then to Optibiotix (OPTI) and Skinbiotherapeutics (SBTX), after today’s news from the latter. I have spoken to both Steve O’Hara and Stuart Ashman. As Les points out in the comments section, the silver lining for you is the postponement of my retirement – but not for long. The market has over-reacted: long-term, these two companies will subsidise the goat farm, as I explain in detail.
800 days ago
As you know I am reviewing my pension as discussed HERE. As such I am chatting to various CEOs who I have backed and yesterday evening I had a long chat with Stuart Ashman of Skinbiotherapeutics (SBTX). He is not a bluffing promoter but, I believe, a sober and grounded chap. I came away from the call just incredibly excited. I explain why the share price is where it is but also why this could within a couple of years be a 10 bagger but it could equally be a 20 bagger. Certainly any free cash within my SIPP will, even at twice today’s price be going into this stock. And if I am right there is a clear implication for Optibiotix (OPTI) so I am not selling any shares in it either. Footnote/correction. There are not 2 million psoriasis sufferers worldwide as per podcast but 120 million. I can’t say that weakens the case!
868 days ago
In today’s podcast I discuss why I worry that my wife may have become a real housewife of posh Cheshire, not the part where they play rugby league. Then I look at ADM Energy (ADME) and that RNS reach issue again, tell you about a psychic moron who owns shares in Supply@ME Capital (SYME) and then I discuss, at length, Skinbiotherapeutics (SBTX) after a chat with CEO Stuart Ashman today and on the back of that I have bought more shares in the company.
896 days ago
As predicted HERE the print going through late on Friday was Optibiotix (OPTI) dumping £2 million worth of Skinbiotherapeutics (SBTX) at 55p. I told you that this would happpen weeks ago producing more bluster and fake denials from all involved. Fuckers! The release this morning insults the intelligence of we loyal shareholders in both companies yet again. Stuart, Steve, posh PR bird Melanie Toyne-Sewell and the scumbags at Cenkos do you think we are idiots? You treat us as if we are.
1199 days ago
And now from Wales, by just 30 yards, it is my new weekly video show. This costs 99p per episode, and you can either listen to, or watch, some sparky interviews with Staurt Ashman of Skinbiotherapeutics (SBTX) where I am 130% up in seven months but think the shares could 20 bag from here and bear raider Lucian Miers on macro economics his cooling feelings on cold and warming feelings on bitcoin and his big longs and shorts. Then there are a few thoughts on companies you must NOT own, including the latest nonsense from the scallywags at Powerhouse Energy (PHE).You can access the show HERE
1290 days ago
Skinbiotherapeutics (SBTX) boss Stuart Ashman until today held zero shares in the company. And he told us all that it had enough cash to last it until the end of next year at least. And so now there is a £4 million placing and £500,000 open offer at 16p. Mr Ashman can you see why I might be annoyed?
1407 days ago
And now from Wales, by just 30 yards, it is my new, I hope, weekly show. This costs 99p per episode, and you can either listen or watch very sparky interviews with our in-house gold guru Nigel Somerville on why you must be in gold and on the stocks or ETFs to own to maximise your bull market gains and with Union Jack Oil (UJO) boss David Bramhill, the most underpaid oil CEO on AIM. I also serve up a red flag-spotting session with reference to Diversified Gas & Oil (DGOC). You can access the show HERE
